ID

14865

Beschrijving

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00050141

Link

https://clinicaltrials.gov/show/NCT00050141

Trefwoorden

  1. 02-05-16 02-05-16 -
  2. 26-06-16 26-06-16 -
Geüploaded op

2 mei 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT00050141

Eligibility Breast Cancer NCT00050141

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
locally advanced, inoperable loco-regionally-recurrent, or metastatic breast cancer
Beschrijving

ID.1

Datatype

boolean

Alias
UMLS CUI [1,1]
C0278493|C0027627
UMLS CUI [1,2]
C0205187
estrogen and/or progesterone positive disease
Beschrijving

ID.2

Datatype

boolean

Alias
UMLS CUI [1]
C0019929
progression of disease after antiestrogen therapy
Beschrijving

ID.3

Datatype

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0279025
measurable disease
Beschrijving

ID.4

Datatype

boolean

Alias
UMLS CUI [1]
C0012634
postmenopausal
Beschrijving

ID.5

Datatype

boolean

Alias
UMLS CUI [1]
C0232970
eastern cooperative oncology group (ecog) performance status 0, 1, or 2.
Beschrijving

ID.6

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous endocrine therapy, other than antiestrogen therapy
Beschrijving

ID.7

Datatype

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0279025
more than 1 prior chemotherapy regimen
Beschrijving

ID.8

Datatype

boolean

Alias
UMLS CUI [1]
C0392920
previous therapy with farnesyl transferase inhibitor
Beschrijving

ID.9

Datatype

boolean

Alias
UMLS CUI [1]
C1517132
presence of rapidly progressive, life-threatening metastases
Beschrijving

ID.10

Datatype

boolean

Alias
UMLS CUI [1,1]
C2826244
UMLS CUI [1,2]
C0027627
concomitant anticancer treatment
Beschrijving

ID.11

Datatype

boolean

Alias
UMLS CUI [1]
C0920425
other malignancy within the past 5 years
Beschrijving

ID.12

Datatype

boolean

Alias
UMLS CUI [1]
C0006826
symptomatic peripheral neuropathy.
Beschrijving

ID.13

Datatype

boolean

Alias
UMLS CUI [1]
C0031117

Similar models

Eligibility Breast Cancer NCT00050141

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
locally advanced, inoperable loco-regionally-recurrent, or metastatic breast cancer
boolean
C0278493|C0027627 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
ID.2
Item
estrogen and/or progesterone positive disease
boolean
C0019929 (UMLS CUI [1])
ID.3
Item
progression of disease after antiestrogen therapy
boolean
C0242656 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
ID.4
Item
measurable disease
boolean
C0012634 (UMLS CUI [1])
ID.5
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
ID.6
Item
eastern cooperative oncology group (ecog) performance status 0, 1, or 2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
previous endocrine therapy, other than antiestrogen therapy
boolean
C0205394 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
ID.8
Item
more than 1 prior chemotherapy regimen
boolean
C0392920 (UMLS CUI [1])
ID.9
Item
previous therapy with farnesyl transferase inhibitor
boolean
C1517132 (UMLS CUI [1])
ID.10
Item
presence of rapidly progressive, life-threatening metastases
boolean
C2826244 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
ID.11
Item
concomitant anticancer treatment
boolean
C0920425 (UMLS CUI [1])
ID.12
Item
other malignancy within the past 5 years
boolean
C0006826 (UMLS CUI [1])
ID.13
Item
symptomatic peripheral neuropathy.
boolean
C0031117 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial